CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX – Get Free Report) was the target of a large decrease in short interest in July. As of July 15th, there was short interest totaling 1 shares, a decrease of 100.0% from the June 30th total of 283,205 shares. Based on an average trading volume of 92,742,631 shares, the days-to-cover ratio is currently 0.0 days.
CNBX Pharmaceuticals Trading Up 100.0%
Shares of CNBX Pharmaceuticals stock opened at $0.00 on Friday. CNBX Pharmaceuticals has a twelve month low of $0.00 and a twelve month high of $0.00.
About CNBX Pharmaceuticals
CNBX Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the research and development of synthetic cannabinoid-based drug candidates. The company’s proprietary platform applies medicinal chemistry techniques to design novel small-molecule analogs of naturally occurring cannabinoids, aiming to improve efficacy and safety compared with existing therapies. Its pipeline includes multiple preclinical compounds targeting neuropathic and chronic pain, with a goal of advancing these candidates through IND-enabling studies.
Headquartered in Costa Mesa, California, CNBX Pharmaceuticals collaborates with contract research organizations and academic partners to conduct pharmacology and toxicology studies as well as scale up manufacturing processes.
Featured Stories
- Five stocks we like better than CNBX Pharmaceuticals
- Telecom Earnings Reveal a Sector That Finally Looks Healthier
- Defense Earnings Show Readiness Now and Modernization Ahead
- Why Palantir Investors Aren’t Panicking While the Rest of AI Sells Off
- MarketBeat Week in Review – 07/20- 07/24
Receive News & Ratings for CNBX Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CNBX Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
